Zeno Equity Partners LLP lessened its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 15.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 223,448 shares of the conglomerate’s stock after selling 42,347 shares during the period. Danaher makes up 20.0% of Zeno Equity Partners LLP’s portfolio, making the stock its 2nd biggest position. Zeno Equity Partners LLP’s holdings in Danaher were worth $51,202,000 at the end of the most recent quarter.
A number of other institutional investors have also recently added to or reduced their stakes in the company. RHL Group LLC purchased a new stake in Danaher during the fourth quarter valued at about $79,000. HBK Sorce Advisory LLC grew its position in Danaher by 141.6% during the fourth quarter. HBK Sorce Advisory LLC now owns 2,653 shares of the conglomerate’s stock valued at $575,000 after acquiring an additional 1,555 shares during the period. Allen Capital Group LLC grew its position in Danaher by 7.7% during the fourth quarter. Allen Capital Group LLC now owns 2,772 shares of the conglomerate’s stock valued at $635,000 after acquiring an additional 198 shares during the period. Simplify Asset Management Inc. grew its position in Danaher by 449.8% during the fourth quarter. Simplify Asset Management Inc. now owns 44,416 shares of the conglomerate’s stock valued at $10,168,000 after acquiring an additional 36,337 shares during the period. Finally, Lathrop Investment Management Co. boosted its position in shares of Danaher by 12.4% in the fourth quarter. Lathrop Investment Management Co. now owns 28,195 shares of the conglomerate’s stock worth $6,454,000 after buying an additional 3,112 shares during the period. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Trading Up 0.1%
Shares of DHR opened at $172.12 on Monday. The company has a market capitalization of $121.82 billion, a P/E ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The stock has a 50-day moving average price of $183.52 and a 200 day moving average price of $208.70.
Danaher Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is presently 30.95%.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the company. Guggenheim decreased their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. JPMorgan Chase & Co. decreased their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. TD Cowen decreased their target price on Danaher from $245.00 to $240.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 target price on Danaher in a research report on Friday, April 17th. Finally, Morgan Stanley decreased their target price on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a research report on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and a consensus target price of $238.65.
Get Our Latest Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
